Athos Asia Event Driven Master Fund - Net Worth and Insider Trading
Athos Asia Event Driven Master Fund Net Worth
The estimated net worth of Athos Asia Event Driven Master Fund is at least $14 Million dollars as of 2024-09-28. Athos Asia Event Driven Master Fund is the 2101 Beneficial owner of Canbridge Pharmaceuticals Inc and owns about 41,891,816 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) stock worth over $14 Million. Details can be seen in Athos Asia Event Driven Master Fund's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Athos Asia Event Driven Master Fund has not made any transactions after 2023-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Athos Asia Event Driven Master Fund
Athos Asia Event Driven Master Fund Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Athos Asia Event Driven Master Fund owns 1 companies in total, including Canbridge Pharmaceuticals Inc (HKSE:01228) .
Insider Ownership Summary of Athos Asia Event Driven Master Fund
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01228 | Canbridge Pharmaceuticals Inc | 2023-12-15 | 2101 Beneficial owner |
Athos Asia Event Driven Master Fund Latest Holdings Summary
Athos Asia Event Driven Master Fund currently owns a total of 1 stock. Athos Asia Event Driven Master Fund owns 41,891,816 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) as of December 15, 2023, with a value of $14 Million.
Latest Holdings of Athos Asia Event Driven Master Fund
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01228 | Canbridge Pharmaceuticals Inc | 2023-12-15 | 41,891,816 | 0.34 | 14,033,758 |
Holding Weightings of Athos Asia Event Driven Master Fund
Athos Asia Event Driven Master Fund Form 4 Trading Tracker
According to the SEC Form 4 filings, Athos Asia Event Driven Master Fund has made a total of 1 transactions in Canbridge Pharmaceuticals Inc (HKSE:01228) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Canbridge Pharmaceuticals Inc is the acquisition of 40,541,216 shares on December 15, 2023, which cost Athos Asia Event Driven Master Fund around $0.
Insider Trading History of Athos Asia Event Driven Master Fund
- 1
Athos Asia Event Driven Master Fund Trading Performance
GuruFocus tracks the stock performance after each of Athos Asia Event Driven Master Fund's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Athos Asia Event Driven Master Fund is -55.41%. GuruFocus also compares Athos Asia Event Driven Master Fund's trading performance to market benchmark return within the same time period. The performance of stocks bought by Athos Asia Event Driven Master Fund within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Athos Asia Event Driven Master Fund's insider trading performs compared to the benchmark.
Performance of Athos Asia Event Driven Master Fund
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 33.78 |  | | | | |
| Relative Return to S&P 500(%) | 32.41 | | | | | |
Athos Asia Event Driven Master Fund Ownership Network
Athos Asia Event Driven Master Fund Owned Company Details
What does Canbridge Pharmaceuticals Inc do?
Who are the key executives at Canbridge Pharmaceuticals Inc?
Athos Asia Event Driven Master Fund is the 2101 Beneficial owner of Canbridge Pharmaceuticals Inc. Other key executives at Canbridge Pharmaceuticals Inc include 2101 Beneficial owner Xue James Qun , 2102 Investment manager Athos Capital Limited , and 2201 Interest of corporation controlled by you Moskey Matthew Love .
Canbridge Pharmaceuticals Inc (HKSE:01228) Insider Trades Summary
Over the past 18 months, Athos Asia Event Driven Master Fund made 1 insider transaction in Canbridge Pharmaceuticals Inc (HKSE:01228) with a net purchase of 40,541,216. Other recent insider transactions involving Canbridge Pharmaceuticals Inc (HKSE:01228) include a net sale of 0 shares made by Xue James Qun , a net purchase of 52,665,590 shares made by Athos Capital Limited , and a net purchase of 52,665,590 shares made by Schulte-Hillen Friedrich Bela .
In summary, during the past 3 months, insiders sold 0 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) were sold and 198,537,986 shares were bought by its insiders, resulting in a net purchase of 198,537,986 shares.
Canbridge Pharmaceuticals Inc (HKSE:01228)'s detailed insider trading history can be found in Insider Trading Tracker table.
Canbridge Pharmaceuticals Inc Insider Transactions
Athos Asia Event Driven Master Fund Mailing Address
Above is the net worth, insider trading, and ownership report for Athos Asia Event Driven Master Fund. Currently GuruFocus does not have mailing address information for Athos Asia Event Driven Master Fund.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
